C9orf72 and amyotrophic lateral sclerosis: Individuals with an initial clinical ALS or FTD syndrome with an underlying TDP-43 proteinopathy are at risk for developing subsequent cognitive-behavioural or motor features, respectively, and this risk is heightened for those with disease due to a C9orf72 hexanucleotide repeat expansion.